Early Stage IT & Healthcare Investing
"The vision for Optimizely is to enable businesses to show exactly the right thing to the right person at the right time. We are glad to have InterWest as partners along our journey to bring that vision to fruition."
Dan Siroker, CEO, Optimizely
"We are very pleased to have InterWest Partners as allies in the delivery of our vision for a new kind of marketing automation solution. This funding has enabled us to rapidly deliver innovative solutions for lead generation, lead nurturing, and marketing accountability."
Phil Fernandez, President and CEO, Marketo
"The RealReal is building the world's largest trusted marketplace for luxury consignment for women and men's fashion, fine jewelry and watches and art. Working with Keval is like have a strategic machine in your midst. He is focused, he is innovative, he is in it to win it and he is fun. "
Julie Wainwright, Founder & CEO, TheRealReal
"Aria Systems provides a cloud based monetization platform that enables Enterprises to optimize their recurring revenue businesses. InterWest has been a great partner, providing expertise on scaling our business operations and rock-solid guidance on our go-to market strategies. "
Tom Dibble, CEO, Aria Systems
"We make physicians more productive and successful by connecting them online—a tricky task that requires an understanding of health care, technology and regulations. With InterWest, we found solid partners with investment, health care and technology expertise under one roof."
Jeff Tangney, CEO, Doximity
""At PMV Pharmaceuticals, we are targeting the most frequently mutated gene in human cancer (p53) to make an unprecedented impact on cancer patients' lives. InterWest Healthcare Partners’ knowledge and understanding of transformative biology made them our ideal lead investor.""
David Mack, Co-Founder, President & CEO, PMV Pharma
"TESARO unearths and passionately pursues the development of biopharmaceuticals that can make a difference in the lives of cancer patients. InterWest’s deep understanding of science and development, along with their investment style, compelled us to partner with them as a foundational investor. "